Gurman Dhillon

[Gurman Dhillon @dhillon795]

God has a tendency of picking up a nobody and making them a somebody, in front of everybody, without asking anybody.
May that person be you!!
#faith #GodDid

[Gurman Dhillon @dhillon795]

@Keemah_00 Brazil

[Gurman Dhillon @dhillon795]

Do you know what's the best gift one can give or receive?
An iPhone? A Birkin Bag? An Expensive Perfume?
No.... It's an Opportunity.
Give more of it & Receive them without guilt.

[Gurman Dhillon @dhillon795]

A LIMS that only manages samples and billing is managing 25% of the revenue opportunity.
The other 75% is leaking silently across these four stages.

Which stage is bleeding most in your lab or LIMS business? Drop it below — or DM me if you'd rather not say it publicly.

[Gurman Dhillon @dhillon795]

Most LIMS manage the lab.
Nobody manages the revenue lifecycle of the patient.

There are 4 stages where money is made or lost in a pathology lab. Most labs only track one of them:

[Gurman Dhillon @dhillon795]

Stage 4 — LTV Locking (Upsell and Repeat)
This is where the business is actually built.
Most labs send a PDF and forget the patient exists.
A smart lab sends a Vitamin D follow-up reminder in 3 months.
Same patient. Zero acquisition cost. Pure revenue.

[Gurman Dhillon @dhillon795]

@CSolsInc Most LIMS solve stage 3. The other three are still bleeding.

[Gurman Dhillon @dhillon795]

@CSolsInc Eliminating transcription errors is the right move, but it only addresses the Lab Floor stage of the revenue leak.
The gap actually lives across 4 stages most LIMS don't touch:
Trust (Referrals) → Front Desk (Cash Capture) → Lab Floor (Margin Erosion) → LTV (Upsells/Repeat)

[Gurman Dhillon @dhillon795]

@ChitriIt28213 Most labs evaluate LIMS on cost & feature count. Both are the wrong filters.
The real question is: does the pricing scale with growth or stay flat while volume gets 2x?

[Gurman Dhillon @dhillon795]

@ChitriIt28213 Unlimited tests sounds like a feature, but it is actually a revenue architecture problem, for the LIMS vendor. The moment a lab outgrows the flat plan, the vendor either absorbs the cost or loses the customer and neither outcome is good for long-term support quality.

[Gurman Dhillon @dhillon795]

@ChitriIt28213 The worst nightmare for a Lab is its 'Downtime' and a LIMS should help in preventing it rather than adding to it, so a lab should only go for LIMS whose business model is aligned with the lab growth.

[Gurman Dhillon @dhillon795]

Most LIMS founders don't have a revenue problem.
They have a visibility problem.
The money is there. It's just escaping through gaps nobody has named yet.
If you run a LIMS business and your margins feel tighter than they should — I'll run this diagnostic on free.
Reply or DM.

[Gurman Dhillon @dhillon795]

Most LIMS businesses aren't low-margin.
They're high-leakage.
Free onboarding. Unlimited support. Flat pricing while usage doubles.
I built a framework to find exactly where the money escapes — and convert it into rupee impact.
Here's how it works 🧵

[Gurman Dhillon @dhillon795]

Step 5: The Founder Message
Everything gets compressed into 2-3 lines.
Not a 40-page deck. Not a strategy document.
A message a founder can read in 30 seconds and immediately know:
what's leaking, how much, and what to fix first.